CVS MAXIMUM STRENGTH URINARY PAIN RELIEF- phenazopyridine hydrochloride tablet
CVS PHARMACY INC
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Phenazopyridine Hydrochloride 99.5 mg .
Do not exceed recommended dosage
■ kidney disease
■ allergies to food, preservatives or dyes
■ had a hypersensitive reaction to phenazopyridine
■ stomach upset may occur, taking this product with or after meals may
reduce stomach upset
■ your urine will become reddish-orange in color. This is not harmful, but
care should be taken to avoid staining clothing or other items.
■ your symptoms last for more than 2 days
■ you suspect you are having an adverse reaction to the medication
Ask a health professional before use.
In case of an overdose, get medical help or contact a Poison Control Center right away.
Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract
Lactose, magnesium silicate, magnesium stearate, microcrystalline cellulose, pharmaceutical glaze, and sodium starch glycolate.
■ adults and children 12 years and over:
take 2 tablets 3 times daily with a full glass of water, with or after meals as needed
■ children under 12 years: consult a doctor
■ Do not use for more than 2 days (12 tablets) without consulting a doctor
|CVS MAXIMUM STRENGTH URINARY PAIN RELIEF phenazopyridine hydrochloride tablet|
|Labeler — CVS PHARMACY INC (062312574)|
|Registrant — Reese Pharmaceutical Co (004172052)|
|Reese Pharmaceutical Co||004172052||relabel (69842-713), repack (69842-713)|
Revised: 09/2021 CVS PHARMACY INC
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.